To whom?
We enthusiastically welcome projects at various stages of development, from start-ups to mature companies, from at pre-clinical or early clinical stages. These projects cover the entire field of oncology and a variety of innovative solutions, including therapies, diagnostics and medical devices. We support French and international companies that contribute to the French economy.
A selective approach
The PSCC concentrates its resources where it can make a difference, i.e. on scientifically creative projects with very high diagnostic or therapeutic potential. To capture the best in discovery and innovation, it relies on a rigorous selection process and an independent evaluation committee made up of experienced scientists and entrepreneurs. Depending on their ranking, selected projects benefit from all or part of the PSCC's offer.
Application deadlines
Applications are assessed on a quarterly basis. For 2025, the application deadlines are : -February 3 -April 28 -August 4 -October 31 To maximize your chances of success, we strongly encourage you to send us your applications sufficiently in advance of the deadline to allow for exchanges with the SOO team and, if necessary, adjustments to your presentation.
Other tips
Be thorough in your analysis of the competition, and clear about your differentiation. The scientific data you provide should be non-confidential, but sufficient to enable us to evaluate your project.
« If your project is selected, the SOO's role will be to coach and support your team, coordinate interactions with partners' scientific offerings, and facilitate connections with experts and potential partners. Please do not hesitate to contact us to find out more about our offer, our expertise and the platforms that are being deployed over time. »
Patricia Zeer PhD, MBA, SOO Member
Our selection criteria
Team quality
Credibility of the scientific team (training, publications, experience, etc.)
Ability of the team to lead the development project and/or be supported by others
Motivation and openness to external contributions
30%
Quality of science
Solidity of initial results
Innovative character
Coherence of scientific strategy
Security of intellectual property
40%
Need to be covered & development opportunities
Patient need not or poorly covered
Transformative potential for patients' lives
Consistency and credibility of development plan
20%
Contribution to cluster objectives
-
Partial or total location on the cluster site, use of several aspects of the offer, commitment to contribute...
-
Job creation potential in France
10%
Your application will be processed by the SOO and evaluated by an independent committee, taking into account the maturity of the project. The aim is to identify projects with the greatest potential for acceleration by the PSCC.
The selection committee is made up of around twenty members from academia and industry. It meets quarterly to re-evaluate the projects received.
Application form
Fill in the form and import your presentation
Each applicant project must provide a powerpoint/PDF file of its presentation in English, including the non-confidential elements below:
-
Slide 1: Summary - synthetic presentation of the project
-
Slide 2 : The medical problem/need targeted by the project
-
Slide 3 : The solution and its innovative character - explain the rationale and level of validation of the project (bibliographic support and/or data generated)
-
Slides 4-6: The science behind the solution - provide results, give full details of experimental protocols, include bibliographical references: For DM: preclinical and/or clinical study(iess), For therapeutic projects: validation(s) of mechanism(s) of action, and/or efficacy data (in vitro, and/or ex vivo and/or in vivo), and/or clinical study(iess), if applicable.
-
Slide 7 : Intellectual property - current/upcoming patents (references), licenses, freedom to operate...
-
Slide 8: Management team, founder and strategic/scientific advisor - with details of previous experience (company names...), and key positions to be recruited if applicable
-
Slide 9: Roadmap - Gantt Chart type: milestones achieved and those to come, with key milestones (“scientific advice”, clinical batch manufacturing, IND, CE marking, etc.). Mention amounts raised to date and those to come.
-
Slide 10 : Competitive landscape and project differentiation - identify competitors and highlight the project's points of differentiation.
-
Slide 11: Support to date - SATT, incubator, consultants, etc.
-
Slide 12 : Expectations and commitments to the PSCC
-
Slide 13 (for projects not based in France only) : Development plan in France: How and when do you plan to develop your presence in France?
Possible appendices - additional scientific and/or medical information
Note: please quote your sources and explain acronyms.